Treatment of Acute Agitation Associated With Excited Catatonia Using Dexmedetomidine: Case Series and Literature Review

Marcela Almeida, MD^a,b; Katherine Cicolello, MD^a,b; Alicia Hanson, MD^c; Gilson DeCavalcante, MD^b; Gildasio S. DeOliveira, MD, MSCI, MBA^d

Prim Care Companion CNS Disord 2021;23(5):20cr02899

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (26)

Cooper JJ, Ross DA. COVID-19 catatonia—would we even know? Biol Psychiatry. 2020;88(5):e19–e21. PubMed CrossRef
Fink M, Taylor MA. Catatonia: subtype or syndrome in DSM? Am J Psychiatry. 2006;163(11):1875–1876. PubMed CrossRef
Bush G, Fink M, Petrides G, et al. Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129–136. PubMed CrossRef
Sienaert P, Rooseleer J, De Fruyt J. Measuring catatonia: a systematic review of rating scales. J Affect Disord. 2011;135(1–3):1–9. PubMed CrossRef
Gee SW, Lin A, Tobias JD. Dexmedetomidine infusion to control agitation due to anticholinergic toxidromes in adolescents, a case series. J Pediatr Pharmacol Ther. 2015;20(4):329–334. PubMed
Talke PO, Maze M. Expecting the unexpected. Anesth Analg. 2008;106(6):1605–1606. PubMed CrossRef
Stuivenga M, Morrens M. Prevalence of the catatonic syndrome in an acute inpatient sample. Front Psychiatry. 2014;5:174. PubMed CrossRef
Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):I8–I13. PubMed CrossRef
Llesuy JR, Medina M, Jacobson KC, et al. Catatonia under-diagnosis in the general hospital. J Neuropsychiatry Clin Neurosci. 2018;30(2):145–151. PubMed CrossRef
Fink M. Delirious mania. Bipolar Disord. 1999;1(1):54–60. PubMed CrossRef
Melo AL, Serra M. Delirious mania and catatonia. Bipolar Disord. 2020;22(6):647–649. PubMed CrossRef
Tobias JD. Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents. J Pediatr Pharmacol Ther. 2010;15(1):43–48. PubMed
Sher Y, Rabkin B, Maldonado JR, et al. COVID-19-associated hyperactive intensive care unit delirium with proposed pathophysiology and treatment: a case report. Psychosomatics. 2020;61(5):544–550. PubMed CrossRef
Ostuzzi G, Gastaldon C, Papola D, et al. Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther Adv Psychopharmacol. 2020;10:2045125320942703. PubMed CrossRef
Detweiler MB, Mehra A, Rowell T, et al. Delirious mania and malignant catatonia: a report of 3 cases and review. Psychiatr Q. 2009;80(1):23–40. PubMed CrossRef
Bobo WV, Murphy MJ, Heckers SH. Recurring episodes of Bell’s mania after cerebrovascular accident. Psychosomatics. 2009;50(3):285–288. PubMed CrossRef
Aksay SS, Bumb JM, Remennik D, et al. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia. Neuropsychiatr Dis Treat. 2017;13:1389–1394. PubMed CrossRef
Narang P, Ianovich F, Sarai SK, et al. Benefits of dexmedetomidine in management of post-ECT agitation. J ECT. 2017;33(3):150–151. PubMed CrossRef
Cohen MB, Stewart JT. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine. J ECT. 2013;29(2):e23–e24. PubMed CrossRef
Maldonado JR, Wysong A, van der Starre PJ, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206–217. PubMed CrossRef
Qiu Z, Zhou S, Zhang M, et al. Preventive effect of dexmedetomidine on postictal delirium after electroconvulsive therapy: a randomised controlled study. Eur J Anaesthesiol. 2020;37(1):5–13. PubMed CrossRef
Mo Y, Zimmermann AE. Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients. Ann Pharmacother. 2013;47(6):869–876. PubMed CrossRef
Rovasalo A, Tohmo H, Aantaa R, et al. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry. 2006;28(4):362–363. PubMed CrossRef
Ward K, Citrome L. The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy. Expert Opin Investig Drugs. 2020;29(3):245–257. PubMed CrossRef
Hammer GB, Drover DR, Cao H, et al. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008;106(1):79–83. PubMed CrossRef
Scarella TM, Teslyar P. Prolonged psychosis with catatonia due to 2,5-dimethoxy-4-bromoamphetamine: case report and literature review. Psychosomatics. 2019;60(6):599–602. PubMed CrossRef